Graft Versus Host Disease Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Graft Versus Host Disease Treatment Market size was estimated at USD 1,421.78 million in 2020 and expected to reach USD 1,557.28 million in 2021, at a CAGR 9% to reach USD 2,764.09 million by 2028.

Graft-versus-host disease (GvHD) is a rare disease in which the donor’s immune cells attack the recipient’s organ tissues after transplant surgery. Occurs after a stem cell or bone marrow transplant. Treatments involving stem cells and bone marrow transplantation are used to repair damaged cells around the cancerous tumor. Usually, after high-dose treatment, the patient receives bone marrow from a donor via a drip to resume blood cell production. When certain types of white blood cells infect a host, the risk of developing GvHD is significantly increased. This is because the transplanted cells (grafts) recognize the recipient’s body (host) as an alien species, and the transplanted cells attack the host’s body. It is difficult to predict who will get GvHD after transplantation. In some cases, a mild form of GvHD is seen. GvHD can be fatal in some situations. GvHD does not occur when the recipient receives his or her own cells via autologous transplantation. Also, symptoms mainly include nausea, diarrhea, skin problems, stomach pain, and liver failure.

Market Segments

On the basis of Types

• Acute Graft Versus Host Disease (aGvHD)
• Chronic Graft Versus Host Disease (cGvHD)

On the basis of Applications

• Monoclonal Antibodies
• MTOR Inhibitors
• Tyrosine Kinase Inhibitors
• Thalidomide
• Etanercept

Key Players

• Bristol-Myers Squibb
• Abbott
• AbbVie
• Allergan
• Anterogen
• Astellas Pharma
• Athersys
• Caladrius
• Eli Lilly
• GlaxoSmithKline
• Glenmark
• Kadmon Holdings
• Osiris Therapeutics
• Sanofi
• Takeda

Scope of the Report

The research study analyzes the global Graft Versus Host Disease Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Graft Versus Host Disease Treatment Market Report

1. What was the Graft Versus Host Disease Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Graft Versus Host Disease Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Graft Versus Host Disease Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.